TickerFacts.

Standard Biotools Inc. (LAB): Share Repurchases

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$40.49M2021-12-31: $02022-12-31: $563.0K2023-12-31: $5.41M2024-12-31: $40.49M2025-12-31: $0$0
2021-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$0-100.0%2026-03-16, From 2025-01-01
2024-12-31$40.49M+647.9%2026-03-16, From 2024-01-01
2023-12-31$5.41M+861.6%2026-03-16, From 2023-01-01
2022-12-31$563.0Kn/a2025-03-11, From 2022-01-01
2021-12-31$0n/a2023-03-14, From 2021-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Standard Biotools Inc. (LAB)2025-12-31$0-100.0%
Siga Technologies Inc (SIGA)2025-12-31$0n/a
Zymeworks Inc. (ZYME)2025-12-31$41.70M+38.7%
Zevra Therapeutics, Inc. (ZVRA)2024-12-31$0-100.0%
Theravance Biopharma, Inc. (TBPH)2024-12-31$445.0K-99.8%
Nektar Therapeutics (NKTR)2025-12-31$0-100.0%
Lexicon Pharmaceuticals, Inc. (LXRX)2024-12-31$1.73M+110.0%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$263.5K-54.5%
Cryoport, Inc. (CYRX)2025-12-31$10.01Mn/a

Compare LAB, SIGA, ZYME, ZVRA side by side · Screen every company in Pharmaceutical Preparations ↗